Net product sales increased 9 percent to $452.2 million through the initial quarter, while Europe net sales decreased 4 percent to $142.9 million and International net product sales increased 11 percent to $112.3 million. Special items for the fiscal 1st quarter totaled $122.7 million, including $74.7 million of noncash amortization expense linked to the 2007 Merger and $48.0 million of special items, primarily linked to the Trauma Acquisition and the business’s stock-based compensation modification. Reported operating income through the first one fourth of fiscal year 2013 was $69.0 million in comparison to operating income of $72.7 million during the first one fourth of fiscal year 2012. Excluding special products, adjusted operating income totaled $191.7 million through the first quarter of fiscal year 2013, in comparison to $182.3 million for the first quarter of fiscal year 2012.Although it has limitations, the ongoing work of Delamarter et al. Should be named the first prospective, randomized study on two-level total disk replacement and one that highlights short-term clinical advantages for the method, such as for example accelerated rehabilitation and enhanced treatment.’ The Journal of Bone and Joint Surgery chose Delamarter’s article for video display and it will be used for surgeon education. The study included 237 sufferers treated from January 2002 to June 2004 by 38 backbone surgeons at 16 sites across the United States.